News summary

Ferring to buy IVF startup Gameto for up to $1.38 billion

Source: Longevity Docs News • Published: 28 Oct 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

Ferring agreed to acquire Gameto, which matures eggs outside the body.

Ferring to buy IVF startup Gameto for up to $1.38 billion
Key Takeaways
  • Gameto uses stem-cell engineered ovarian support cells.
  • A randomized phase 3 trial is still enrolling patients.
  • Regulatory approval and long-term outcomes remain uncertain.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?